Statistics for Oramed Pharmaceuticals (id:5652 ORMP)

Valuation metrics

Market cap

89.90M

Enterprise value

-52,894,088.00

Trailing P/E (ttm)

20.27

Forward P/E

-27.88

PEG ratio

-27.88

Price/Sales (ttm)

67.09

Price/Book (mrq)

0.57

Enterprise Value/Revenue

-39.47

Enterprise Value/EBITDA

4.12

Overview

Shares outstanding

40.31M

Float

33.66M

Shares short

299.98K

% Held by insiders

0.11%

% Held by institutions

0.18%

Average volume (10 days)

124.40K

Average volume (90 days)

Price summary

52-Week low

2.00

52-Week high

3.67

52-Week change

7.26%

Beta

1.77

50-Day moving average

2.38

200-Day moving average

2.52

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

January 23th, 2013

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

531.72%

Operational effectiveness

Return on assets

-4.12%

Return on equity

2.89%

Income statement

Revenue (ttm)

0.03

Revenue per share (ttm)

0.03

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-12,848,000.00

Net income to common (ttm)

4.46M

Diluted EPS (ttm)

0.11

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

142.30M

Total cash per share (mrq)

3.53

Total debt (mrq)

429.00K

Total Debt/Equity (mrq)

0.28

Current ratio (mrq)

2.71K%

Book value per share (mrq)

3.89

Cash flow

Cash flow statement

-7,919,000.00

Levered free cash flow (LFCF)

-2,407,375.00